Under Armour heads into its May 14 earnings release from a deeply uncomfortable position: the stock has lost 17% in a single day, bears already own more than a fifth of the float, and options traders have been positioned defensively for weeks.
The short interest story dominates the setup. At 22.3% of the free float — one of the heavier short burdens in the apparel sector — the bearish conviction here is substantial. Notably, ORTEX estimates put the figure at roughly 42 million shares as of May 11, down about 7% on the week, suggesting some bears trimmed into the sell-off rather than pressing the position. Days to cover runs at 5.8 days, giving any relief rally meaningful squeeze fuel. Borrow remains cheap at 0.55%, down sharply over the past month, and availability is well within normal ranges — nothing in the lending market signals an imminent squeeze. The ORTEX short score of 72 ranks in the 3rd percentile of the universe, confirming shorts remain firmly in control of the narrative.
Options positioning reinforces the caution. The put/call ratio has run persistently elevated — at 1.92 against a 20-day average of 1.88 — for most of the past month, a level more than double the broader market norm. The 52-week range on PCR runs from 0.45 to 3.47, so the current reading reflects a market that has been defensively positioned for some time, not a fresh panic trade. What is fresh is the price damage: UAA closed at $5.03 on May 12, down 17% in one session, 20% on the week and 18% over the past month. By contrast, closest peers and fell 3% and 4% on the week — UAA's losses are largely its own story, not a sector washout.
The bull and bear debate splits on the credibility of the turnaround. Bulls point to operating metrics that came in above consensus last quarter — strong SG&A discipline and a sales beat — and to the factor data: EPS surprise ranks in the 100th percentile and 90-day EPS momentum scores at the 97th percentile, suggesting the company has consistently outrun low expectations. The counter is structural: wholesale and direct-to-consumer channels are both declining, the Curry brand wind-down removes a growth lever, and tariff exposure is set to weigh on near-term profitability. Analyst consensus has drifted toward hold, with Goldman Sachs and Barclays both lifting targets in February to $7 and $8 respectively — still well above the current $5.03 — after last quarter's beat. Citi moved to Sell at $6.20 on the same day. All of this analyst activity is now three months old; the stock has since shed around 40% from where those targets were set, so the targets carry limited forward signal. One notable anchor: Fairfax Financial has been a consistent buyer, accumulating roughly 65 million shares and spending over $116 million in the 90 days to late January — a meaningful vote of confidence from a long-horizon holder, even as the stock has moved against them.
Tomorrow's print will test whether Q4 results and any FY27 guidance can justify the turnaround thesis at a price where even the bears' targets now look optimistic.
See the live data behind this article on ORTEX.
Open UAA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
